DermTech, Inc.
DMTK · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $15,296 | $14,518 | $11,838 | $5,885 |
| % Growth | 5.4% | 22.6% | 101.2% | – |
| Cost of Goods Sold | $15,020 | $13,871 | $10,564 | $5,981 |
| Gross Profit | $276 | $647 | $1,274 | -$96 |
| % Margin | 1.8% | 4.5% | 10.8% | -1.6% |
| R&D Expenses | $15,239 | $24,052 | $16,261 | $5,293 |
| G&A Expenses | $43,781 | $36,086 | $24,836 | $13,823 |
| SG&A Expenses | $88,776 | $94,760 | $62,411 | $29,900 |
| Sales & Mktg Exp. | $44,995 | $58,674 | $37,575 | $16,077 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $104,015 | $118,812 | $78,672 | $35,193 |
| Operating Income | -$103,739 | -$118,165 | -$77,398 | -$35,289 |
| % Margin | -678.2% | -813.9% | -653.8% | -599.6% |
| Other Income/Exp. Net | $2,851 | $1,482 | -$937 | -$1,188 |
| Pre-Tax Income | -$100,888 | -$116,683 | -$78,335 | -$36,477 |
| Tax Expense | $0 | -$2,964 | -$1,359 | -$526 |
| Net Income | -$100,888 | -$116,683 | -$78,335 | -$36,477 |
| % Margin | -659.6% | -803.7% | -661.7% | -619.8% |
| EPS | -3.09 | -3.88 | -2.71 | -2.05 |
| % Growth | 20.4% | -43.2% | -32.2% | – |
| EPS Diluted | -3.09 | -3.88 | -2.71 | -2.05 |
| Weighted Avg Shares Out | 32,641 | 30,039 | 28,885 | 16,979 |
| Weighted Avg Shares Out Dil | 32,641 | 30,039 | 28,885 | 16,979 |
| Supplemental Information | – | – | – | – |
| Interest Income | $2,846 | $1,341 | $151 | $40 |
| Interest Expense | $0 | $1,341 | $0 | $40 |
| Depreciation & Amortization | $5,846 | $4,460 | $2,296 | $486 |
| EBITDA | -$97,893 | -$110,882 | -$75,102 | -$34,803 |
| % Margin | -640% | -763.8% | -634.4% | -591.4% |